Annex 1-compliant production cell with gloveless isolator and integrated air treatment is designed to offer new technological advances in aseptic filling.
Has capacity for large molecule biologics, including proteins, next to oligonucleotides (DNA, recombinant RNA, synthetic RNA, RNA vaccines) and peptides.
Strengthens capabilities in developing and manufacturing single-use containers, handling equipment and accessories for the pharma and biopharma markets.